Department of Urology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Curr Urol Rep. 2014 Jun;15(6):409. doi: 10.1007/s11934-014-0409-2.
In 2008, urothelial carcinoma of the bladder (UCB) was the 8th most common cause of death in Germany. An increasing body of evidence suggests differences in the presentation and prognosis of UCB between genders. Large population-based and multi-institutional studies have found a higher incidence of UCB in men, while women treated with radical cystectomy (RC) have shown unfavorable outcomes compared to their male counterparts. Indeed, it is important to note that UCB incidence and outcomes have regional and country-specific variability. These distinct country and gender-specific differences must be considered in patient counseling, treatment decisions, and UCB management. This review summarizes the contemporary literature regarding the impact of gender on UCB outcomes, focusing on patients treated with RC in Germany. We evaluated the most current literature regarding gender-specific differences in UCB incidence, treatment patterns, and oncological outcomes, including pathological stage distribution and survival.
2008 年,膀胱癌(UCB)是德国第 8 位最常见的死亡原因。越来越多的证据表明,性别之间 UCB 的表现和预后存在差异。大型基于人群的多机构研究发现,男性 UCB 的发病率更高,而接受根治性膀胱切除术(RC)治疗的女性与男性相比,预后不佳。事实上,值得注意的是,UCB 的发病率和结果在区域和国家之间存在差异。在患者咨询、治疗决策和 UCB 管理中,必须考虑到这些不同的国家和性别特异性差异。本综述总结了关于性别对 UCB 结果影响的当代文献,重点关注在德国接受 RC 治疗的患者。我们评估了关于 UCB 发病率、治疗模式和肿瘤学结果(包括病理分期分布和生存)的最新性别差异的文献。